Literature DB >> 8594431

Androgens in men--uses and abuses.

C J Bagatell1, W J Bremner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8594431     DOI： 10.1056/NEJM199603143341107

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  57 in total

1.  Analysis of 19-nortestosterone residue in animal tissues by ion-trap gas chromatography-tandem mass spectrometry.

Authors:  Jin-qing Jiang; Lei Zhang; Guang-ling Li; Hai-tang Zhang; Xue-feng Yang; Jun-wei Liu; Ren-feng Li; Zi-liang Wang; Jian-hua Wang
Journal:  J Zhejiang Univ Sci B       Date:  2011-06       Impact factor: 3.066

2.  Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.

Authors:  Andrew Stolz; Victor Navarro; Paul H Hayashi; Robert J Fontana; Huiman X Barnhart; Jiezhun Gu; Naga P Chalasani; Maricruz M Vega; Herbert L Bonkovsky; Leonard B Seeff; Jose Serrano; Bharathi Avula; Ikhlas A Khan; Elizabeth T Cirulli; David E Kleiner; Jay H Hoofnagle
Journal:  Aliment Pharmacol Ther       Date:  2019-04-01       Impact factor: 8.171

Review 3.  Neuropsychiatric effects of prescription drug abuse.

Authors:  Jason P Caplan; Lucy A Epstein; Davin K Quinn; Jonathan R Stevens; Theodore A Stern
Journal:  Neuropsychol Rev       Date:  2007-08-16       Impact factor: 7.444

4.  Potent, nonsteroidal selective androgen receptor modulators (SARMs) based on 8H-[1,4]oxazino[2,3-f]quinolin-8-ones.

Authors:  Robert I Higuchi; Anthony W Thompson; Jyun-Hung Chen; Thomas R Caferro; Marquis L Cummings; Charlotte P Deckhut; Mark E Adams; Christopher M Tegley; James P Edwards; Francisco J López; E Adam Kallel; Donald S Karanewsky; William T Schrader; Keith B Marschke; Lin Zhi
Journal:  Bioorg Med Chem Lett       Date:  2007-07-25       Impact factor: 2.823

5.  Urinary and serum hormones profiles after testosterone enanthate administration in male hypogonadism: concerns on the detection of doping with testosterone in treated hypogonadal athletes.

Authors:  L Di Luigi; P Sgrò; F Romanelli; M Mazzarino; F Donati; M C Braganò; S Bianchini; V Fierro; M Casasco; F Botrè; A Lenzi
Journal:  J Endocrinol Invest       Date:  2009-03-24       Impact factor: 4.256

6.  A selective androgen receptor modulator with minimal prostate hypertrophic activity enhances lean body mass in male rats and stimulates sexual behavior in female rats.

Authors:  George F Allan; Pamela Tannenbaum; Tifanie Sbriscia; Olivia Linton; Muh-Tsann Lai; Donna Haynes-Johnson; Sheela Bhattacharjee; Xuqing Zhang; Zhihua Sui; Scott G Lundeen
Journal:  Endocrine       Date:  2007-10-02       Impact factor: 3.633

7.  Enhanced evaluation of selective androgen receptor modulators in vivo.

Authors:  M Otto-Duessel; M He; T W Adamson; J O Jones
Journal:  Andrology       Date:  2012-08-28       Impact factor: 3.842

Review 8.  Androgen replacement therapy: present and future.

Authors:  Louis J G Gooren; Mathijs C M Bunck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.

Authors:  Norman Mangner; Yae Matsuo; Gerhard Schuler; Volker Adams
Journal:  Endocrine       Date:  2012-08-19       Impact factor: 3.633

Review 10.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.